GlassScriptPhysician profile
Andres G Santiviago
NPI 1457342149
$1,411.31
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $73.37 · 2021: $355 · 2022: $296 · 2023: $265 · 2024: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $210.56 | 2022-2023 | Ova1 |
| Coopersurgical, INC. | $203.06 | 2021-2023 | Summit Doppler |
| Abbvie INC. | $202.68 | 2019-2021 | |
| Baxter Healthcare | $151.71 | 2020-2022 | |
| Hologic INC | $129.04 | 2021 | |
| Kci USA, INC. | $125.00 | 2019 | |
| Sumitomo Pharma America, INC. | $111.34 | 2024 | Myfembree |
| Novo Nordisk INC | $107.10 | 2023 | Wegovy |
| Boston Scientific Corporation | $89.50 | 2019 | |
| Smith+Nephew, INC. | $81.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Santiviago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.